Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Promising E. Coli Vaccine Fizzles in Late-Stage Trial

(MedPage Today) -- An investigational vaccine targeting the Escherichia coli pathogens that commonly cause infections didn't show a protective effect in older adults, the phase III E.mbrace trial found. Among over 17,000 participants ages 60 and...

Promising E. Coli Vaccine Fizzles in Late-Stage Trial

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Real-World Treatment Choices for AMD

(MedPage Today) -- Poor adherence to anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) remains a major limitation of existing therapies, a review of a large clinical database…

More from Wednesday 14 October →